Georgia Life Sciences Names 2025 Golden Helix Award Winners

Academic Innovators and Industry Leaders to be Honored at the Georgia Life Sciences Summit 

August 12, 2025 - The Georgia Life Sciences Golden Helix Awards celebrate excellence and achievement across Georgia’s life sciences ecosystem, recognizing the individuals, companies, and institutions making significant contributions to scientific discovery, health innovation, and economic growth in the state and beyond. 


This year’s winners will be honored at the welcome reception and awards ceremony on day one of the Georgia Life Sciences Summit, August 26-27 at the Sandy Springs Performing Arts Center.


We are pleased to announce this year’s slate of 2025 Golden Helix Award winners: 


PHOENIX AWARD: Boehringer-Ingelheim / University of Georgia  for the Sustainable Development Excellence Certificate Program 

This award, sponsored by the Metro Atlanta Chamber, celebrates an industry/academic collaboration, or other allied partnership, that demonstrate strength, tenacity, and leadership. Like the mythical phoenix, together they exemplify how strategic partnerships can accelerate discovery, fuel commercialization, and create meaningful impact for patients and communities. 


INNOVATION AWARD: Myomatrix

Presented to an institution, team, or individual whose innovation goes beyond the traditional paradigms and has the potential to significantly impact human health, agriculture, or environmental sustainability. Eligible innovations may include—but are not limited to—advancements in biotechnology, pharmaceuticals, diagnostics, medical devices, digital health, or life science-related AI and data platforms. 


DEAL OF THE YEAR AWARD

  • Andson Biotech (Private Financing), biotools company revolutionizing sample preparation for mass spectrometry workflows, for closing a $3.6M seed round led by industry veterans and expanding from three to ten employees while launching its DynaChip X1 platform into commercial markets. 
  • Micron Biomedical (Private Financing), for securing $16M to expand manufacturing of its needle-free vaccine delivery technology and advance multiple vaccine candidates toward commercialization.
  • Moonlight Therapeutics (Private Financing), or closing its first equity round, Series A, co-led by Portal Innovations, to advance its novel intradermal allergen immunotherapy platform for treating food allergies, beginning with MOON101 for peanut allergy.
  • Synaptrix (Private Financing), a medical device company developing the groundbreaking NOVABLOC™ system for drug-free postoperative pain management, for raising $13M in Series A funding led by Hatteras Venture Partners to support pivotal studies, regulatory submission, and commercialization.
  • ANI Pharmaceuticals (Acquisition) for its definitive agreement to acquire Alimera Sciences, for $453M, expanding its global footprint and portfolio to three commercial rare disease assets.
  • Stryker (Acquisition), for its definitive agreement to acquire Artelon, expanding its portfolio of soft tissue fixation solutions for orthopedic surgeons.
  • Duracell (Economic Development), for selecting Georgia as the site of its new North American R&D headquarters, further strengthening the state’s life sciences and advanced manufacturing ecosystem. 

Presented to a company or institution who has made the most significant transaction of the year (between January 1, 2024-March 31, 2025), a deal that exemplifies strategic vision, market influence, and long-term value creation. Whether it’s a transformative partnership, acquisition, licensing agreement, IPO, or major funding round, this deal represents a defining moment for the companies involved and a milestone for the state’s biotech ecosystem.  

 

COMMUNITY AWARD:

  • ARCS Foundation – Atlanta
  • Jeffrey Gray, Founder and CEO, AgeTech Atlanta
  • Christopher Kunney, Managing Partner and Digital Transformation Strategist, IOTech Consulting, LLC
  • Lisa Middleton, Ph.D., Director, Scientific Affairs, Georgia Cancer Center/Augusta University

Presented to a life sciences organization or individual that has demonstrated continuous commitment to making a positive, lasting impact on their local community. This award recognizes organizations/ individuals that go beyond their day-to-day operations through career development initiatives, outreach programs, patient advocacy, corporate philanthropy, or other significant community contribution.

 

EMERGING LEADER OF THE YEAR AWARD: Benjamin Siciliano, PhD, Radyus Research 

Presented to an individual in the first decade of their career whose achievements are significantly contributing to or transforming the life sciences industry. 


TEACHER OF THE YEAR AWARD: Amanda Barrett, Marietta High School 

Presented to a Georgia biotechnology high school teacher who exhibits innovative teaching, mentorship, and unwavering dedication to inspire the next generation of thinkers, problem-solvers, and future leaders in STEM/ biotechnology.


LEGISLATOR OF THE YEAR AWARD: Senator Chuck Hufstetler, 52nd District, Rome

Honors select legislators in recognition of their leadership in advancing federal and state policies to promote life sciences research, investment, and innovation. 


Winners are selected by the Golden Helix Awards Committee, a select group of leaders from Georgia’s life sciences, academic, and business communities who are responsible for identifying and recommending the most impactful individuals, companies, and organizations for recognition at the Golden Helix Awards. The committee reviews nominations across categories including scientific advancement, public policy, entrepreneurship, education, and community impact, aligning with the mission of the Golden Helix Awards to honor those whose ideas and achievements are leading the way in health and science.


To register for the summit, click here.

November 6, 2025
GLS President & CEO, Maria Thacker Goethe Recognized as One of Georgia's 2025 Top 500 Most Influential Leaders
By Maria Thacker Goethe October 22, 2025
“Evolving FTC and DOJ policies leave investors and innovators navigating a cautious M&A landscape
October 6, 2025
Atlanta, GA — October 6 — Georgia Life Sciences today announced the launch of Vitals, a new podcast series developed in partnership with Cloudcast Media, a leader in branded podcast production. The series will spotlight the people, ideas, and innovations shaping the future of Georgia’s rapidly growing life sciences sector. Hosted by Georgia Life Sciences’ CEO, Maria Thacker Goethe, Vitals will feature in-depth conversations with scientists, entrepreneurs, investors, educators, policymakers, and patient advocates. Each episode will explore the challenges and opportunities facing Georgia’s life sciences ecosystem—spanning biopharma, medical technology, digital health, and advanced manufacturing. “Vitals gives us a powerful platform to showcase the remarkable work happening within our state,” said Maria Thacker Goethe. “By sharing these stories, we’re highlighting not only groundbreaking science but also the collaboration and talent that make Georgia such a vibrant hub for health innovation.” Cloudcast Media, known for its expertise in storytelling and high-quality podcast production, will bring industry insights and technical support to ensure the series reaches audiences across Georgia and beyond. “We’re proud to partner with Georgia Life Sciences on Vitals,” said Charles Parisi, Founder and CEO of Cloudcast. “This series will elevate the voices of innovators who are advancing science, improving patient outcomes, and building Georgia’s reputation as a global life sciences leader. We are very excited that Cloudcast Atlanta can play a role in supporting Maria and the impactful work of Georgia Life Sciences.” The first episode of Vitals launched today and is available on Apple Podcasts, Spotify, and other major streaming platforms, as well as through the Georgia Life Sciences website.
MORE POSTS